| 000 | 00929 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250513062048.0 | ||
| 264 | 0 | _c19940412 | |
| 008 | 199404s 0 0 eng d | ||
| 022 | _a0891-1150 | ||
| 024 | 7 |
_a10.3949/ccjm.61.1.38 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPohl, M A | |
| 245 | 0 | 0 |
_aChanging the course of diabetic nephropathy: angiotensin-converting enzyme inhibition in type I diabetic renal disease. _h[electronic resource] |
| 260 |
_bCleveland Clinic journal of medicine _c |
||
| 300 |
_a38-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aCaptopril _xtherapeutic use |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 773 | 0 |
_tCleveland Clinic journal of medicine _gvol. 61 _gno. 1 _gp. 38-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3949/ccjm.61.1.38 _zAvailable from publisher's website |
| 999 |
_c8124170 _d8124170 |
||